Thermo Fisher reported revenue for the quarter grew 5% to $11.40 billion in 2024 versus the same quarter of 2023. Organic revenue growth was 4% and “core” organic revenue growth was 5%.

We recently published a list of the 10 Best Medical Device Stocks To Buy According to Hedge Funds. In this article, we are ...

Thermo Fisher Scientific's instruments, equipment, software, services and consumables address a range of needs from sample, ...

Thermo Fisher Scientific Inc. (NYSE:TMO), a leading player in the Life Science Tools & Diagnostics sector, has been navigating a complex market landscape characterized by both challenges and ...

We recently published a list of 10 Best Manufacturing Stocks To Buy Now. In this article, we are going to take a look at where Thermo Fisher Scientific Inc.

Thermo Fisher's unique scale and breadth of products and services have allowed the company to grow market share, and it can continue to do so. This supports the above market long-term growth ...

Thermo Fisher is a scientific industry support company. It offers products and services for the chemical, medical, and biopharma industries across the globe, but mainly in North America and Europe ...

Thermo Fisher Scientific on Thursday forecast annual profit above Wall Street estimates, banking on improved demand for its products and services used in developing therapies, sending its shares up 6.

Life sciences company Thermo Fisher (NYSE:TMO) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 4.7% year on year to $11.4 billion. Its non-GAAP profit of $6.10 per ...

Thermo Fisher Scientific Inc (TMO) reports robust Q4 performance with significant revenue and EPS growth, while navigating ...